Food Processing Industries Secretary Avinash Joshi said that the upcoming policy will focus on boosting domestic ...
Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...
Nigeria chairs the ECOWAS food fortification program, aiming for 70-100% compliance to combat hidden hunger and micronutrient ...
Al Jazeera on MSN
Why el-Obeid matters as Sudan’s war enters a new phase
How fighting for el-Obeid could shape both Sudan’s war and its humanitarian crisis.
Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced results from two Phase 1/2 ...
Hamas says it will hand Gaza’s government to a technocratic committee, but questions remain over disarmament and Israel’s ...
A novel intravitreal axitinib hydrogel demonstrated durable disease control in patients with treatment-naive neovascular age-related macular degeneration (AMD), with superior maintenance of visual ...
Merck, a leading science and technology company, today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to enpatoran for the treatment of lupus ...
As India's health-conscious consumers increasingly embrace protein-rich diets, nutrition brands are partnering with coffee ...
GlobalData on MSN
Prilenia and Ferrer begin phase III trial of Huntington’s therapy
The study plans to enrol 400 participants living with early to mid-stage HD.
The FDA has accepted for review a Biologics License Application for ReNu, an amniotic suspension allograft, to treat symptomatic knee osteoarthritis pain.
EMD Serono Announces FDA Breakthrough Therapy Designation for Enpatoran in Lupus Patients with Active Skin Manifestations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results